Introduction
Patients and methods
Clinical data
Hyperbaric oxygen therapy
Examination
Clinical evaluation
Statistical analysis
Results
General clinical characteristics
Brain injury (n = 54) | Consciousness disorder (n = 32) | Non-consciousness disorder (n = 22) | P value | |
---|---|---|---|---|
Median age (years) | 47 ± 14 | 52 ± 14 | 50 ± 13 | 0.734 |
Gender (male = n%) | 39 (72%) | 27 (84%) | 13 (59%) | 0.052 |
Time from onset to surgery | 0.009 | |||
No surgery | 19 | 5 | 14 | |
Day 0–1 | 26 | 22 | 4 | |
Day 2 | 6 | 4 | 2 | |
Day 3–4 | 3 | 1 | 2 | |
Etiologies of brain injury | ||||
Spontaneous intracerebral hemorrhage | 31 | 23 | 8 | 0.010 |
Basal ganglia | 13 | 11 | 2 | 0.260 |
Brain stem | 2 | 0 | 2 | 0.013 |
Cerebellum | 2 | 2 | 0 | 0.389 |
Frontal Lobe; Parietal Lobe; Temporal Lobe | 3 | 2 | 1 | 0.754 |
Other | 11 | 8 | 3 | 0.890 |
Subarachnoid hemorrhage | 10 | 4 | 6 | 0.170 |
Cerebral contusion and laceration | 7 | 1 | 6 | 0.009 |
Extradural hemorrhage | 3 | 2 | 1 | 0.788 |
Subdural hemorrhage | 2 | 1 | 1 | 0.786 |
Intracranial aneurysm | 1 | 1 | 0 | 0.403 |
Clinical symptoms | ||||
Conscious disturbance | 32 | 32 | 0 | 0.000 |
Headache and dizziness | 17 | 7 | 7 | 0.413 |
Nausea and vomiting | 16 | 10 | 6 | 0.753 |
Transient loss of consciousness | 8 | 0 | 8 | 0.000 |
Limb weakness | 8 | 5 | 3 | 0.840 |
Urinary incontinence | 4 | 4 | 0 | 0.000 |
Others (inarticulate, defect of visual field, blurred vision) | 6 | 1 | 5 | 0.024 |
GCS score on admission | ||||
3–8 | 24 | |||
9–12 | 7 | |||
13–15 | 1 | |||
MMSE score on admission | ||||
0–9 | 0 | |||
10–20 | 5 | |||
21–27 | 17 |
Brain injury (n = 54) | Conscious disturbance (n = 32) | Non-conscious disturbance (n = 22) | P value | |
---|---|---|---|---|
Time from onset to HBOT | 0.065 | |||
Day 0–14 | 4 | 1 | 3 | |
Day 15–21 | 18 | 9 | 9 | |
Day ≥ 22 | 32 | 22 | 10 | |
Hempill score | 0.017 | |||
0–1 | 1 | 4 | ||
2 | 3 | 3 | ||
3 | 3 | 1 | ||
4 | 12 | 1 | ||
≥ 5 | 3 | 1 | ||
Marshall CT classification | 0.140 | |||
1 | 2 | 7 | ||
2 | 1 | 0 | ||
3 | 2 | 0 | ||
4 | 0 | 2 | ||
5 or 6 | 5 | 2 |
Comparison of clinical data between brain injury group and control group
Category | Brian injury group(n = 54) | Control group (n = 11) | P |
---|---|---|---|
Age | 47 ± 14 | 51 ± 14 | 0.321 |
Gender (male = n%) | 39 (72%) | 6 (54%) | 0.200 |
β2MG before HBOT | 2.64 ± 0.79 | 1.73 ± 0.39 | 0.001 |
β2MU before HBOT | 6.82 ± 20.2 | 0.17 ± 0.16 | 0.006 |
SCR before HBOT | 52 ± 14 | 64 ± 11 | 0.016 |
BUN before HBOT | 5.3 ± 2.2 | 4.3 ± 1.2 | 0.190 |
β2MG after 1st course HBOT | 2.58 ± 0.76 | 1.73 ± 0.39 | 0.002 |
β2MU after 1st course HBOT | 2.07 ± 7.46 | 0.17 ± 0.16 | 0.258 |
SCR after 1st course HBOT | 47 ± 16 | 64 ± 11 | 0.004 |
BUN after 1st course HBOT | 4.4 ± 1.4 | 4.3 ± 1.2 | 0.907 |
β2MG after 2nd course HBOT | 2.14 ± 0.66 | 1.73 ± 0.39 | 0.067 |
β2MU after 2nd course HBOT | 0.65 ± 2.09 | 0.17 ± 0.16 | 0.308 |
SCR after 2nd course HBOT | 47 ± 15 | 64 ± 11 | 0.004 |
BUN after 2nd course HBOT | 4.1 ± 1.3 | 4.3 ± 1.2 | 0.715 |
Comparison of data between the conscious disturbance group and non-conscious disturbance group
Category | Conscious disturbance group(n = 32) | Non-conscious disturbance group(n = 22) | P |
---|---|---|---|
Age | 52 ± 14 | 50 ± 13 | 0.734 |
Gender (male = n%) | 27 (84%) | 13 (59%) | 0.052 |
β2MG before HBOT | 2.89 ± 0.88 | 2.20 ± 0.96 | 0.009 |
β2MU before HBOT | 10.78 ± 20.2 | 1.76 ± 7.02 | 0.035 |
SCR before HBOT | 52 ± 15 | 53 ± 14 | 0.878 |
BUN before HBOT | 5.6 ± 2.5 | 4.7 ± 1.5 | 0.208 |
β2MG after 1st course HBOT | 2.77 ± 0.65 | 2.02 ± 0.49 | 0.029 |
β2MU after 1st course HBOT | 3.36 ± 9.03 | 0.28 ± 0.28 | 0.384 |
SCR after 1st course HBOT | 47 ± 17 | 47 ± 13 | 0.978 |
BUN after 1st course HBOT | 4.3 ± 1.2 | 4.5 ± 2.1 | 0.848 |
β2MG after 2nd course HBOT | 2.59 ± 0.76 | 1.79 ± 0.35 | 0.025 |
β2MU after 2nd course HBOT | 1.15 ± 2.64 | 0.13 ± 0.89 | 0.366 |
SCR after 2nd course HBOT | 48 ± 15 | 45 ± 18 | 0.783 |
BUN after 2nd course HBOT | 4.2 ± 1.5 | 4.0 ± 1.2 | 0.868 |
Analysis of the variation tendency of β2MG and β2MU’s concentrations
Time point | Group | Machly W | P1 | F | P2 | |||||
---|---|---|---|---|---|---|---|---|---|---|
Brain injury group | Conscious disturbance group | Non-conscious disturbance group | Time | Time*group | Time | Time*group | ||||
β2MG | Before HBOT After 1st course After 2nd course | 2.64 ± 0.79 2.58 ± 0.76 2.14 ± 0.66 | 2.89 ± 0.88 2.77 ± 0.65 2.59 ± 0.76 | 2.38 ± 0.48 2.30 ± 0.79 1.73 ± 0.30 | 0.881 | 0.091 | 10.251 | 0.189 | 0.000 | 0.929 |
β2MU | Before HBOT After 1st course After 2nd course | 6.82 ± 20.2 2.07 ± 7.46 0.65 ± 2.09 | 10.78 ± 20.2 3.36 ± 9.03 1.15 ± 2.64 | 0.52 ± 0.50 0.15 ± 0.12 0.11 ± 0.03 | 0.181 | 0.000 | 38.000 | 39.000 | 0.059 | 0.026 |
Analysis of the variation tendency of serum creatinine and blood urea nitrogen’s concentrations
Variable | Before HBOT | After 1st course of HBOT | After 2nd course of HBOT | Machly W | P1 | F | P2 |
---|---|---|---|---|---|---|---|
SCR | 52 ± 14 | 47 ± 17 | 48 ± 15 | 0.589 | 0.054 | 0.665 | 0.477 |
BUN | 5.3 ± 2.2 | 4.3 ± 1.2 | 4.2 ± 1.5 | 0.647 | 0.092 | 4.538 | 0.035 |